Received Mar 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 95BJ9 | IM / RA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 1 | W1C831M | SC / LA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Y008284 | SC / RA |
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | LN75D | IM / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | X449Y | IM / LA |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | Y008284 | OT / RA |
No adverse effects reported; improperly stored PROQUAD; This spontaneous report was received from an Other health professional and refers to an 11-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included Hbhepb (Hepatitis b vaccine;HIB vaccine), Ipol (Polio vaccine inact 3v (Vero)), Men (Meningococcal vaccine), Boostrix (Diphtheria vaccine toxoid;Pertussis vaccine acellular 3-component;Tetanus vaccine toxoid) . The Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live lyophilisate and solvent for solution for injection (PROQUAD) was moved to the refrigerators on 01-OCT-2024 where it remained within normal refrigerated temperature (36 to 46 degrees Fahrenheit) until administration. The patient received the first dose of improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live lyophilisate and solvent for solution for injection (PROQUAD) subcutaneously at right arm on 04-DEC-2024 for prophylaxis since it "was stored in the refrigerator for months" instead of the freezer (lot # Y008284, expiry date: 21-OCT-2025) (Product storage error). No adverse effects reported (no adverse event). This is one of many reports from the same reporter.
Hep B; Inactive polio virus; Meningococcal; Tdap (Boostrix); Sterile Diliuent